1: Tallman MS. Related Articles, Links
Advancing the treatment of hematologic malignancies through the development of targeted interventions.
Semin Hematol. 2002 Oct;39(4 Suppl 3):1-5.
PMID: 12447845 [PubMed - in process]
2: Nimmanapalli R, Fuino L, Stobaugh C, Richon VM, Bhalla K. Related Articles, Links
Co-treatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances Gleevec-induced apoptosis of Bcr-Abl positive human acute leukemia cells.
Blood. 2002 Nov 21 [epub ahead of print]
PMID: 12446442 [PubMed - as supplied by publisher]
3: Bohmer FD, Karagyozov L, Uecker A, Serve H, Botzki A, Mahboobi S, Dove S. Related Articles, Links
A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP-site inhibitor STI-571.
J Biol Chem. 2002 Nov 14 [epub ahead of print]
PMID: 12435730 [PubMed - as supplied by publisher]
4: Kizaki M, Nakazato T, Ito K, Kawamura C, Miyakawa Y, Ikeda Y. Related Articles, Links
A novel therapeutic approach for hematological malignancies based on cellular differentiation and apoptosis.
Int J Hematol. 2002 Aug;76 Suppl 1:250-2.
PMID: 12430859 [PubMed - in process]
5: Griesinger F, Janke A, Podleschny M, Bohlander SK. Related Articles, Links
Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line.
Br J Haematol. 2002 Nov;119(2):454-8.
PMID: 12406085 [PubMed - indexed for MEDLINE]
Time used: 47 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005